On the afternoon of September 13, the "Financial Support Enterprise Innovation and Entrepreneurship and Bank of Nanjing Joint Investment and Promotion Seminar" was successfully held in Holiday Inn Taizhou China Medical City. Bank of Nanjing and Jiangsu Zecen Biotech Co., Ltd. signed a strategic cooperation agreement on investment and loan business . Mr. Chen, director of Bank of Nanjing Taizhou Branch, Li Jinbing, deputy director of Taizhou Financial Office and deputy director of Taizhou Medicine High-tech Zone, Liu Zhenguo, General Manager of Jiangsu Zecen Biotech Co., Ltd. attended the signing ceremony.
At the meeting, General Manager Liu Zhenguo as the only representative of the enterprise introduced the details of the cooperation between banks and enterprises at the current stage. He thought that through cooperation on investment and loan as "small equity and big claims" with Bank of Nanjing, Zecen Biotech has benefited a lot. Firstly, it helps company to create a safe, stable and timely funding chain to solve the company's development fund and avoid any worry. Secondly, it helps to protect the funding shareholders’ rights and interests. Thirdly, it helps to enhance the company's brand image. At the seminar, General Manager Liu Zhenguo pointed out that after a three-year cooperation with Bank of Nanjing, Zecen Biotech had completed all the infrastructure, and the sales volume is increasing year by year and the sales are expected to have a major breakthrough in 2017.
At the end of the seminar, Bank of Nanjing Taizhou Branch and Jiangsu Zecen Biotech Co., Ltd. signed a contract of "investment and loan". Mr.Liu expressed his hope that through the cooperation mode of "investment and loan", we could keep the long-term and stable relationship with Bank of Nanjing and achieve a win-win result.